Israeli App Wins FDA Clearance to Adjust Insulin Doses Without Waiting for Doctor
Israeli startup DreaMed Diabetes's MODI app gains FDA clearance, empowering type 2 diabetes patients to adjust insulin doses via smartphone without physician.
U.S. Food and Drug Administration
RedHill Biopharma Drug Gets FDA Boost for Treating Childhood Cancer
RedHill Biopharma's investigational drug opaganib has received FDA rare pediatric disease designation for treating neuroblastoma in children.
Israel’s MeMed Wins FDA Breakthrough Status for AI-Powered Infection Test
Haifa-based MeMed's AI-powered MeMed BV Flex test, distinguishing bacterial from viral infections in 15 minutes, earns FDA Breakthrough Device Designation.